1. Home
  2. AAT vs NVAX Comparison

AAT vs NVAX Comparison

Compare AAT & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

HOLD

Current Price

$24.31

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.51

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAT
NVAX
Founded
1967
1987
Country
United States
United States
Employees
208
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
AAT
NVAX
Price
$24.31
$7.51
Analyst Decision
Sell
Hold
Analyst Count
2
9
Target Price
$19.50
$11.33
AVG Volume (30 Days)
367.5K
3.6M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
6.65%
N/A
EPS Growth
N/A
309.76
EPS
0.08
N/A
Revenue
$436,204,000.00
$1,123,479,000.00
Revenue This Year
$4.33
N/A
Revenue Next Year
$0.22
N/A
P/E Ratio
$303.00
N/A
Revenue Growth
N/A
64.69
52 Week Low
$17.72
$6.20
52 Week High
$25.97
$11.85

Technical Indicators

Market Signals
Indicator
AAT
NVAX
Relative Strength Index (RSI) 44.43 30.13
Support Level $23.69 $6.38
Resistance Level $24.85 $10.10
Average True Range (ATR) 0.49 0.37
MACD -0.21 -0.14
Stochastic Oscillator 15.31 2.03

Price Performance

Historical Comparison
AAT
NVAX

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: